WINDGO, Inc., a research and development company specializing in smart material and vibrational transfer technologies, announced today that they have been granted US Patent No. 10,376,423 for an invention that will provide Internet of Things (IoT) sensory and response communications to devices worn on human and animal bodies.
A group of Canadian plastic surgeons have used 3D printing to create a realistic hand model to help young surgeons learn valuable surgical skills.
GI Alliance (GIA), the nation's largest independent gastroenterology services organization, today announced a partnership with Illinois Gastroenterology Group (IGG). With IGG and Texas Digestive Disease Consultants (TDDC) as partner practices, GIA now represents over 215 physicians in over 140 locations across three states.
A cost-effectiveness analysis completed by the University of California, San Francisco (UCSF) and Baylis Medical has shown that use of Baylis' RF transseptal needle results in cost savings per procedure, compared to use of a mechanical transseptal needle.
Affinity Biosensors announced that George Goedesky has joined its team as Vice President of Sales and Marketing. He will lead the rollout of the LifeScale AST system for rapid antibiotic susceptibility tests, now in U.S. clinical trials for identifying targeted therapy for sepsis.
Jubilant DraxImage Inc. ("DraxImage"), a wholly owned subsidiary of Jubilant Pharma Limited, is pleased to announce the receipt of the CE Mark certificate for its state-of-the-art RUBY Rubidium Elution System (RbES) and the proprietary RUBY consumable accessories dedicated for use with their RUBY-FILL® (Rubidium Rb82 Generator).
Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced today that it is launching the Scope Pro-tech endoscopic tip protector, made possible through an exclusive distribution agreement with Meditech Endoscopy Ltd.
Bruker today announced an agreement to develop the world's first 18 Tesla 11 cm bore, preclinical ultra-high field (UHF) magnetic resonance imaging (MRI) system and its clinical research applications in collaboration with the Champalimaud Foundation.
A cancer diagnosis is overwhelming, intimidating, and frightening. Treatment plans often include surgery, weeks of radiation therapy, numerous chemotherapy infusions, or a combined approach of various therapies that can cause mild to severe discomfort, among other side effects.
Xstrahl Medical, global leader in superficial radiotherapy devices to treat non-melanoma skin cancer and dermatological conditions, is launching its latest superficial radiotherapy treatment system.